Tower Research Capital (TRC)’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
1CP
CA
Tower Research Capital (TRC)'s BME Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of BlackRock Health Sciences Trust (BME) in Q2 2024, closing a stake of 142 shares — an estimated $5.88K sold.
Tower Research Capital (TRC) first reported a position in BME in Q2 2013 and held it in 13 quarters. The position peaked at $107K in Q4 2014. 69 funds tracked by Wall St. Rank hold BME as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining BlackRock Health Sciences Trust position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 142 BlackRock Health Sciences Trust shares in Q2 2024, an estimated $5.88K.
- Tower Research Capital (TRC) first reported a position in BlackRock Health Sciences Trust in Q2 2013 and held it in 13 quarters.
- Tower Research Capital (TRC)'s BlackRock Health Sciences Trust position peaked at $107K in Q4 2014.
- 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.